Registry for patients with congenital heart disease
Invasive Hemodynamic Control Cohort for The Mayo Clinic Adult Congenital Heart Disease (MACHD) Registry
This study is gathering information from adults with congenital heart disease to better understand their health and improve care for them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT05849025 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather comparative data for the Mayo Clinic Adult Congenital Heart Disease Registry. It will involve patients who meet specific health criteria, including those with a BMI of 30 or less and stable blood pressure levels. Participants will undergo assessments to ensure they can consent and meet kidney function requirements. The study will help enhance understanding of congenital heart disease in adults.
Who should consider this trial
Good fit: Ideal candidates are adults with congenital heart disease who meet specific health criteria and can undergo an MRI.
Not a fit: Patients with a history of cardiovascular disease or those currently taking cardiac medication may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management and treatment strategies for adults with congenital heart disease.
How similar studies have performed: Other studies have shown success in utilizing registries for congenital heart disease, indicating this approach is supported by prior research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Capacity to Consent * BMI \</= 30 * Systolic BP \</= 140mmHg * Diastolic BP \</= 90 * eGFR \> 30 (within prior 3 months) to confirm kidney function * Able to undergo an MRI Exclusion Criteria: * History of Cardiovascular disease that may affect the results of the testing performed. * Any Current orthopedic limitations * Currently taking any cardiac medication * Pregnancy
Where this trial is running
Rochester, Minnesota
- Mayo Clinic Rochester — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Alexander Egbe, MBBS, MPH — Mayo Clinic
- Study coordinator: ACHD Research Program
- Phone: (507) 293-2565
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.